2',3-Dichloro-[1,1'-biphenyl]-4-carboxylic acid, 96%, 1g

2-(6-METHOXY-PYRIDIN-2-YL)-ETHYLAMINE HCL, 95.0%, 250mg

(S)-1-(4-((tert-Butyldimethylsilyl)oxy)phenyl)ethan-1-amine, 98%, 5g

2-(2,6-Difluoro-3-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95%, 1g

Methyl 3-morpholinecarboxylate hydrochloride, 95.0%, 5g

2-Bromo-5,6-dichloropyridin-3-amine, 95.0%, 2g

4-Methyl-3-nitrobenzaldehyde, 96.0%, 25g

2-(3,4-Epoxycyclohexyl)ethyltrimethoxysilane>97.0%(GC)25mL

2-Chloro-5,6,7,8-tetrahydroquinolin-5-ol, 95.0%, 250mg

Accessories exchange block for reaction vessels, Gesch. for, 24 reaction vials 1.5 ml, 1 piece

Ethyl 2-acetylbenzoate, 97.0%, 250mg

2-Chloro-N-(5-propyl-1,3,4-thiadiazol-2-yl)acetamide, 95.0%, 5g

BENZYL ((5-METHYLPIPERIDIN-2-YL)METHYL)CARBAMATE HCL, 95.0%, 500mg